| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CBSTF | Common Shares | Sale | $34,680 | -100,000 | -0.47% | $0.3468 | 21,327,075 | 21 Nov 2023 | Held by Vita Holdings LLC | F1, F5 |
| transaction | CBSTF | Common Shares | Sale | $18,035 | -50,000 | -0.23% | $0.3607 | 21,277,075 | 22 Nov 2023 | Held by Vita Holdings LLC | F2, F5 |
| transaction | CBSTF | Common Shares | Sale | $17,600 | -50,000 | -0.23% | $0.3520 | 21,227,075 | 27 Nov 2023 | Held by Vita Holdings LLC | F3, F5 |
| transaction | CBSTF | Common Shares | Sale | $17,785 | -50,000 | -0.24% | $0.3557 | 21,177,075 | 27 Nov 2023 | Held by Vita Holdings LLC | F4, F5 |
| holding | CBSTF | Common Shares | 618,950 | 21 Nov 2023 | Direct |
| Id | Content |
|---|---|
| F1 | The sales price reported above was converted from the Canadian sales price of C$0.475 using an exchange rate of C$1.3698 = US$1.00. |
| F2 | The sales price reported above was converted from the Canadian sales price of C$0.495 using an exchange rate of C$1.3723 = US$1.00. |
| F3 | The sales price reported above was converted from the Canadian sales price of C$0.48 using an exchange rate of C$1.3635 = US$1.00. |
| F4 | The sales price reported above was converted from the Canadian sales price of C$0.485 using an exchange rate of C$1.3635 = US$1.00. |
| F5 | Shares sold by third-party financial institution in partial satisfaction of debt obligation. Funding was primarily used for pediatric medical research for orphan and ultra rare illnesses, tax payments, educational and philanthropic purposes. |